Perfil
En la actualidad, James P. Bilotta ocupa el cargo de Director de Información y Vicepresidente de Alnylam Pharmaceuticals, Inc. Anteriormente fue Director de Tecnología de la Información en Purdue Pharma LP y Director de Información y Vicepresidente en Alexion Pharmaceuticals, Inc. James P. Bilotta obtuvo un MBA y una licenciatura en la Southern Connecticut State University.
Cargos activos de James Bilotta
| Empresas | Cargo | Inicio |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/08/2024 |
Antiguos cargos conocidos de James Bilotta.
| Empresas | Cargo | Fin |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/08/2024 |
| ALEXION PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/01/2014 |
Purdue Pharma LP
Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Director Técnico/Científico/I+D | 01/04/2004 |
Formación de James Bilotta.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Purdue Pharma LP
Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Distribution Services |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Southern Connecticut State University
Southern Connecticut State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
- Bolsa de valores
- Insiders
- James Bilotta
















